Danielle Hanke
Student
Doctor of Philosophy in Pharmaceutical Sciences (PhD)
Pharmaceutical Sciences covers research areas of nanomedicine, drug delivery; drug metabolism, pharmacokinetics and toxicology; pharmacogenomics and pharmacogenetics; diabetes, cardiovascular and molecular pharmacology; neuropharmacology; cancer pharmacology; pharmaceutical health outcomes and pharmacotherapeutics; and pharmaceutical education.
| Name | Research Interests |
|---|---|
| Beedle, Aaron | |
| Cairns, Brian | Neurosciences, biological and chemical aspects; Neurosciences, medical and physiological and health aspects; Pharmacology and pharmaceutical sciences (except clinical aspects); electrophysiology; headache; Neuropharmacology; Oro-Facial Pain; pain; pain mechanisms; peripheral analgesics; sex-related differences; temporomandibular disorders |
| Chang, Thomas | Pharmacology and pharmaceutical sciences (except clinical aspects) |
| Cheng, Miffy | nanomedicine; gene therapy to combat chronic diseases |
| Conklin, Annalijn | Public health nutrition policy; Other basic medicine and life sciences; Social Determinants of Dietary and Metabolic Disorders; social nutritional epidemiology; women's health; Health Equity; Chronic Diseases in Elderly; Obesity; CVD risk factors; healthy ageing; food and nutrition policy; Indigenous health; Community Health / Public Health; disease management evaluation; healthcare quality improvement |
| Coughtrie, Michael | Drug metabolizing enzymes |
| Cragg, Jacquelyn | Epidemiology (except nutritional and veterinary epidemiology); data science; open science; Causal inference; Drug Effectiveness; Drug Safety; Epidemiology; neuro-epidemiology; Neurological diseases; Spinal cord injury; Amyotrophic Lateral Sclerosis (ALS); multiple sclerosis; Parkinson’s disease |
| De Vera, Mary | examining how eHealth technologies can support new and existing models of care to improve care delivery and patient outcomes; exploring patients' perspectives and experiences with medication taking and adherence; and evaluating the use and impacts of medications among pregnant women, particularly with inflammatory conditions. |
| Finbloom, Joel | Drug discovery, design and delivery; Biologically active molecules; Nanochemistry; Antimicrobial resistance; Nanomedicine; nanomedicine; Chemical Biology; drug delivery; Pharmaceutical Sciences; Infectious disease; Bacterial Biofilms; Microbiome; Probiotics; Antibiotic resistance |
| Frankel, Adam | Enzymes (including kinetics and mechanisms, and biocatalyst); Other basic medicine and life sciences; Protein Biochemistry; arginine methylation; Histones; Nucleosomes; post-translational modifications; Biological and Biochemical Mechanisms; Organic Molecules and Biomolecules; Bioactive Molecules; Proteins; Target Engagement; Chemical Biology; drug discovery; Amino acids |
| Giaever, Guri | Model organisms, human therapeutics, high-throughput cell biology, drug synergy, technologies for understanding relationship between chromatic structure and transcriptional regulation |
| Harrison, Mark | measurement and valuation of health, health technology and policy assessment, and preferences for healthcare interventions; evaluation/re-evaluation of the type of health care that is provided, the point in the treatment pathway, and the way in which it is delivered |
| Hedtrich, Sarah | Pharmacology and pharmaceutical sciences (except clinical aspects); Nanotechnology; Bioengineering Human (Disease) Models; Gene Therapy; Human Epithelia; Next-Generation Therapies for Inflammatory and Genetic Diseases of Human Epithelia; Topical drug delivery and Nanomedicine; Nanotechnology, Bioengineering Human (Disease) Models, Gene Therapy, Human Epithelia, Next-Generation Therapies for Inflammatory and Genetic Diseases of Human Epithelia, Topical Drug Delivery and Nanomedicine |
| Jarvis-Selinger, Sandra | Education, human learning, development, and instruction, education innovation, konwledge translation, teaching excellence, curriculum design, technology |
| Johnson, Kate | Health care effectiveness and outcomes; Health economics; Health outcomes; Epidemiology |
| Kilgore, Henry | Chemical Biology; Cell Biology; Machine Learning; Artificial Intelligence |
| Krentz, Nicole | Human development and organogenesis; Pharmacology and pharmaceutical sciences, n.e.c.; Human physiology, n.e.c.; Diabetes; Developmental biology; Genetics; Diabetes, Developmental Biology, Genetics |
| Kumar, Ujendra | Somatostatin hormone, molecular pharmacology, Somatostatin, , Hormones, somatostatin, locomotor and cognitive function, neurodegenerative diseases, drugs |
| Lalji, Fawziah | Pharmacoepidemiology; Infectious diseases; Immunization; Antibiotics and Resistance; Vaccine preventable diseases; Pharmacoepidemiology, Infectious Diseases, Immunization, Antibiotics and Resistance, Vaccine preventable diseases |
| Li, Shyh-Dar | Drug discovery, design and delivery; Nano-technology; biopharmaceutics; drug delivery; nanomedicine; pharmaceutics; Gene delivery and therapy; Regenerative medicine; Localized drug delivery; Biopharmaceutics, Drug delivery, Nanomedicine, Pharmaceutics, Gene delivery and therapy, Regenerative medicine, Localized drug delivery |
| Loewen, Peter | Cardiology and circulatory sciences (including cardiovascular disease); Clinical pharmacy and pharmacy practice; Knowledge translation and implementation science in health; Population health interventions; atrial fibrillation; Pharmacoepidemiology; Thrombosis and Embolism; adherence to medication; Cardiovascular diseases; Arrhythmia; Heart Failure; stroke; Health Care Technologies; Professional Practices; Hematology; decision making; clinical prediction rules; hospital pharmacy practice; knowledge translation of evidence to patient care; patient complexiometry; patient decision aids; patient education; pharmacy practice; prediction of stroke and bleeding in atrial fibrillation patients; quality of care, quality drug therapy; Shared decision-making; stroke prevention therapy; use of mobile technology for clinical decision-making |
| Lynd, Larry | health economics, orphan drugs, pharmaceutical policy, respiratory medicine, epidemiology, pharmacoepidemiology, rare diseases |
| Maharaj, Anil | Pharmacology and pharmaceutical sciences, n.e.c.; Pharmacometrics; Pharmacokinetics/Pharmacodynamics; Obstetric and Pediatric Pharmacology |
| McCormack, James | Knowledge translation and evidence-based practice; Knowledge translation and evidence-based practice |
| Nislow, Corey | Genomics; Mechanisms of carcinogenesis; genomics; Genetics; drug discovery; Biotechnology; Space Biology; Genomics, genetics, Drug Discovery, Biotechnology, Space Biology |